Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Parkin anticorps (pSer378)

PARK2 Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN361515
  • Antigène Voir toutes Parkin (PARK2) Anticorps
    Parkin (PARK2) (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
    Épitope
    • 17
    • 16
    • 16
    • 9
    • 9
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer378
    Reactivité
    • 84
    • 34
    • 33
    • 6
    • 3
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 107
    • 7
    • 2
    Lapin
    Clonalité
    • 110
    • 6
    Polyclonal
    Conjugué
    • 55
    • 6
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Cet anticorp Parkin est non-conjugé
    Application
    • 98
    • 39
    • 39
    • 39
    • 23
    • 20
    • 16
    • 16
    • 9
    • 5
    • 4
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Specificité
    Specific for the ~52k parkin protein phosphorylated at Ser378. Immunolabeling of the parkin band is absent in parkin S378 mutants.
     Réactivité croisée
    Humain
    Purification
    Antigen Affinity Purified
    Immunogène
    Synthetic phospho-peptide corresponding to amino acid residues surrounding Ser378 conjugated to KLH
    Top Product
    Discover our top product PARK2 Anticorps primaire
  • Indications d'application
    Recommended Dilution: WB: 1:1000 Quality Control: Western blots performed on each lot.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    100 μL in 10 mM HEPES (  pH 7.5), 150 mM NaCl, 100 μg per ml BSA and 50 % glycerol.
    Stock
    -20 °C
  • Antigène
    Parkin (PARK2) (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
    Autre désignation
    PARK2 (PARK2 Produits)
    Synonymes
    anticorps CG10523, anticorps Dmel\\CG10523, anticorps Dpark, anticorps SD01679, anticorps dpk, anticorps AR-JP, anticorps LPRS2, anticorps PDJ, anticorps PRKN, anticorps Park, anticorps Prkn, anticorps si:ch211-123f21.1, anticorps zgc:112390, anticorps pdr-1, anticorps PARK2, anticorps parkin, anticorps parkin RBR E3 ubiquitin protein ligase, anticorps Parkinson disease (autosomal recessive, juvenile) 2, parkin, anticorps park, anticorps PRKN, anticorps Prkn, anticorps prkn, anticorps CpipJ_CPIJ014867, anticorps Park2
    Sujet
    Parkin is an E3 ligase in the ubiquitin-proteasome system. Hereditary Parkinson’s disease is most commonly caused by mutations in the parkin gene and is characterized by the progressive loss of dopaminergic neurons and the presence of Lewy bodies in the substania nigra (Jenner et al.,1992). Recent evidence suggests that phosphorylation of parkin at Ser378 may have an important regulatory role on its E3 ubiquitin ligase activity (Yamamoto et al., 2005). Anti-Phospho-Ser378 Parkin Western blot of HEK293 cells transfected with Parkin WT (Phospho) and Parkin S378 mutant (non-phospho) showing the phospho-specific immunolabeling of the ~ 52 k parkin protein. The immunolabeling is absent in the parkin S378 mutant.
    Poids moléculaire
    '52 kDa
    ID gène
    5071
    UniProt
    O60260
    Pathways
    Autophagy, Ubiquitin Proteasome Pathway
Vous êtes ici:
Support technique